Teva Pharmaceutical Industries Ltd (TEVA)

35.08
0.05 0.14
NYSE : Health Care
Prev Close 35.03
Open 35.21
Day Low/High 34.62 / 35.32
52 Wk Low/High 34.57 / 66.55
Volume 5.73M
Avg Volume 9.17M
Exchange NYSE
Shares Outstanding 1.01B
Market Cap 37.60B
EPS 1.80
P/E Ratio 7.35
Div & Yield 1.36 (3.70%)

Latest News

Teva Pharmaceutical Is Down to Key Support. Did I Say Key?

Teva Pharmaceutical Is Down to Key Support. Did I Say Key?

Wait for a bounce and then a retest before stepping up to buy.

Questions Mount at Teva as Generics Head Quits Without Explanation

Questions Mount at Teva as Generics Head Quits Without Explanation

Siggi Olfasson is poised to step down as president and CEO of Teva's global generic medicines group by the end the first quarter of 2017.

Teva Receives Positive Outcome For COPAXONE® Label In Europe

Teva Receives Positive Outcome For COPAXONE® Label In Europe

Teva Pharmaceutical Industries Ltd. (NYSE and TASE:TEVA) today announced that it has received a positive outcome through the variation procedure to remove the pregnancy contraindication from the European label for...

Teva Appoints Dipankar Bhattacharjee As President And Chief Executive Officer, Global Generic Medicines Group, Succeeding Siggi Olafsson

Teva Appoints Dipankar Bhattacharjee As President And Chief Executive Officer, Global Generic Medicines Group, Succeeding Siggi Olafsson

Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that Dipankar Bhattacharjee has been appointed President and Chief Executive Officer, Global Generic Medicines Group, effective today.

Allergan Seeks to Reassure Antsy Investors but Will They Buy It?

Allergan Seeks to Reassure Antsy Investors but Will They Buy It?

Will investors want to wait 12 to 18 months to see Allergan's deals pay dividends?

Teva To Present Oncology Data At The 2016 American Society Of Hematology (ASH) Annual Meeting & Exposition

Teva To Present Oncology Data At The 2016 American Society Of Hematology (ASH) Annual Meeting & Exposition

Teva Pharmaceutical Industries Ltd., (NYSE and TASE:TEVA) today announced that data on GRANIX ® (tbo-filgrastim) Injection, TREANDA ® (bendamustine HCl) Injection and TRISENOX ® (arsenic trioxide) Injection...

Some 'January Effect' Stock Picks

Some 'January Effect' Stock Picks

Small-caps could also benefit from abating tax-loss selling.

Allergan Could Pay $1 Billion for Chase Pharma

Allergan Could Pay $1 Billion for Chase Pharma

'Milestone payments' could boost deal's $125 million announced price.

Teva Pharmaceutical Industries Limited Investors With Losses In Excess Of $1,000,000 Are Reminded To Contact The Rosen Law Firm Regarding The Important Deadline In Class Action Filed By Firm - TEVA

Teva Pharmaceutical Industries Limited Investors With Losses In Excess Of $1,000,000 Are Reminded To Contact The Rosen Law Firm Regarding The Important Deadline In Class Action Filed By Firm - TEVA

Rosen Law Firm, a global investor rights law firm, reminds purchasers of the American Depositary Shares ("ADSs") of Teva Pharmaceutical Industries Limited (NYSE:TEVA) between February 10, 2015 and November 3, 2016, both...

Teva Secures European Approval Of Trisenox® For First Line Treatment Of Low To Intermediate Risk Acute Promyelocytic Leukemia (APL)

Teva Secures European Approval Of Trisenox® For First Line Treatment Of Low To Intermediate Risk Acute Promyelocytic Leukemia (APL)

Teva Pharmaceutical Industries Ltd., (NYSE and TASE:TEVA) today announced it has obtained approval from the European Commission for an indication extension of Trisenox ® (arsenic trioxide).

INVESTOR ALERT: Brower Piven Encourages Shareholders Who Have Losses In Excess Of $100,000 From Investment In Teva Pharmaceutical Industries Limited To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit

INVESTOR ALERT: Brower Piven Encourages Shareholders Who Have Losses In Excess Of $100,000 From Investment In Teva Pharmaceutical Industries Limited To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit

The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the Central District of California on behalf...

Nokia, Teva Pharmaceutical and Vodafone Are Volatile; Here's Why

Nokia, Teva Pharmaceutical and Vodafone Are Volatile; Here's Why

As the broader markets surge, these three stocks are falling. Are any of them value plays?

Analysts' Actions -- Disney, Fitbit, Fossil, Lululemon, Sysco and More

Analysts' Actions -- Disney, Fitbit, Fossil, Lululemon, Sysco and More

Here are Wednesday's top research calls, including upgrades for Disney, Fitbit and Fossil, and downgrades for Lululemon Athletica and Sysco.

Robbins Arroyo LLP: Teva Pharmaceutical Industries Ltd. (TEVA) Misled Shareholders According To A Recently Filed Class Action

Robbins Arroyo LLP: Teva Pharmaceutical Industries Ltd. (TEVA) Misled Shareholders According To A Recently Filed Class Action

Shareholder rights law firm Robbins Arroyo LLP announces that a class action complaint was filed against Teva Pharmaceutical Industries Ltd.

Cramer: This Is No Time to Dog-Paddle

Cramer: This Is No Time to Dog-Paddle

In these market crosscurrents, it's tough to go with the flow.

Teva Shares Lower on Third-Quarter Results

Teva Shares Lower on Third-Quarter Results

Teva's revenue was helped by its acquisition of Allergan's generics business in the third quarter, though sales nonetheless missed estimates.

Teva Reports Third Quarter 2016 Results

Teva Reports Third Quarter 2016 Results

Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) today reported results for the quarter ended September 30, 2016.

Rosen Law Firm Announces Filing Of Securities Class Action Lawsuit Against Teva Pharmaceutical Industries Limited - TEVA

Rosen Law Firm Announces Filing Of Securities Class Action Lawsuit Against Teva Pharmaceutical Industries Limited - TEVA

Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the American Depositary Shares ("ADSs") of Teva Pharmaceutical Industries Limited (NYSE:TEVA)...

Pfizer Finds Breaking Up Is Hard to Do

Pfizer Finds Breaking Up Is Hard to Do

Pfizer stock took a dive. Now what?

War and Peace in Trumpland: Here Is Why You Buy These 4 Stocks Now

War and Peace in Trumpland: Here Is Why You Buy These 4 Stocks Now

After the shocking election results, the stock market supplied its own surprise and rallied Wednesday. These four gainers should continue thriving under a Donald Trump presidency.

INVESTOR ALERT: Law Offices Of Howard G. Smith Commences Investigation On Behalf Of Teva Pharmaceuticals Investors Concerning Recent Revelations Regarding An Alleged Illegal Conspiracy To Fix Drug Prices

INVESTOR ALERT: Law Offices Of Howard G. Smith Commences Investigation On Behalf Of Teva Pharmaceuticals Investors Concerning Recent Revelations Regarding An Alleged Illegal Conspiracy To Fix Drug Prices

Law Offices of Howard G. Smith announces an investigation on behalf of investors of Teva Pharmaceuticals ("Teva" or the "Company") (NYSE: TEVA) concerning recent reports that the Company has unlawfully colluded with...

IMPORTANT SHAREHOLDER ALERT: Lundin Law PC Announces Securities Class Action Lawsuit Against Teva Pharmaceutical Industries Limited And Encourages Investors With Losses To Contact The Firm

IMPORTANT SHAREHOLDER ALERT: Lundin Law PC Announces Securities Class Action Lawsuit Against Teva Pharmaceutical Industries Limited And Encourages Investors With Losses To Contact The Firm

Lundin Law PC, a shareholder rights firm, announces a class action lawsuit has been filed against Teva Pharmaceutical Industries Limited ("Teva" or the "Company") (NYSE: TEVA) concerning possible violations of federal...

Teva Announces Appointment Of New Chief Legal Officer

Teva Announces Appointment Of New Chief Legal Officer

Teva Pharmaceutical Industries Ltd. (NYSE:TEVA)(TASE:TEVA) today announced the appointment of Mr.

IMPORTANT INVESTOR ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit Against Teva Pharmaceutical Industries Limited And Encourages Investors With Losses To Contact The Firm

IMPORTANT INVESTOR ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit Against Teva Pharmaceutical Industries Limited And Encourages Investors With Losses To Contact The Firm

Khang & Khang LLP (the "Firm") announces the filing of a class action lawsuit against Teva Pharmaceutical Industries Limited ("Teva" or the "Company") (NYSE: TEVA).

Impax is Slowly Stealing Market Share from Mylan, but Manufacturing Could Get in the Way

Impax is Slowly Stealing Market Share from Mylan, but Manufacturing Could Get in the Way

Impax makes a generic version of Adrenaclick, a competitor to Mylan's EpiPen.